Viewing Study NCT05940961


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-02-08 @ 3:45 PM
Study NCT ID: NCT05940961
Status: RECRUITING
Last Update Posted: 2025-11-21
First Post: 2023-07-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL
Sponsor: Sheng-Li Xue, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module